Investors can check their Sahajanand Medical Technologies IPO allotment status on the BSE, NSE, or MUFG Intime India websites. The issue got subscribed 14.20 times, with strong interest from institutional buyers. Shares traded at a grey market premium of Rs 24, suggesting a potential listing price of Rs 368 per share.
Its share price band was fixed at Rs 327 to Rs 344 per share. Motilal Oswal Investment Advisors is the book-running lead manager for the issue, while MUFG Intime India is acting as the registrar.
In case you wish to check your IPO allotment status, here’s a quick and easy guide
Here’s a quick and easy guide to check your IPO allotment status online.
Sahajanand Medical Technologies IPO: How to check IPO allotment status
Via BSE Website
Go to the BSE IPO allotment status page.
Select ‘Equity’ as the issue type.
From the dropdown, choose ‘Sahajanand Medical Technologies’.
Enter your application number or PAN.
Complete the captcha by ticking ‘I’m not a robot’ and click on Search.
Via NSE Website
Visit the NSE IPO application tracking page.
Then, click on ‘Equity and SME IPO Bid Details’.
Select ‘Sahajanandi’ from the list.
Provide details such as your application number and PAN.
Submit to view your allotment status.
Via the Registrar’s Website
Go to the official site of the Registrar, MUFG Intime India.
Select ‘Sahajanand’’ from the dropdown.
Choose any of the following: PAN, Application Number, DP ID/Client ID, or Bank Account Number.
Fill in the necessary details and press Search to check your status.
Sahajanand Medical Technologies IPO: Subscription snapshot
The Sahajanand Medical Technologies IPO witnessed strong investor participation, as by the end of its bidding window, the issue was subscribed 14.20 times. QIBs led the pack; however, the employees’ quota was undersubscribed
Qualified Institutional Buyers (QIBs): 34.70 times
Non-Institutional Investors (NIIs): 14.64times
Retail Investors: 3.03 times
Employees: 0.37 times
Sahajanand Medical Technologies IPO: Grey Market Activity
As per the latest update, the shares of the medtech firm were trading in the unlisted markets at a grey market premium of Rs 24, suggesting a likely listing price of Rs 368, based on the upper end of the price band. This equates to gains of 6.98% per share and a profit of Rs 1,032 per lot.
However, GMP is an unofficial metric to determine the listing price and fluctuates based on market mood and sentiment.